IMVEXXY - Why Choose Imvexxy from Mayne Pharma on Vimeo.

Why Choose IMVEXXY?

Because caring for you and your vagina at your age and stage of life is important.

Why Choose IMVEXXY?

Because caring for you and your vagina at your age and stage of life is important. IMVEXXY was made to treat moderate to severe painful sex due to menopause without inconveniencing you or your vagina.



Here are some benefits of
choosing IMVEXXY:

Fast-Acting

Ultra-Low Dose

Mess-Free
Administration
 

FAST-ACTING

WORKS, AND WORKS FAST.

In as fast as 2 weeks, IMVEXXY starts treating the actual problem behind vaginal pain and discomfort due to estrogen loss.

In a study of menopausal women who used IMVEXXY for 12 weeks, most experienced relief from moderate to severe painful sex. In fact, many women started experiencing relief in as fast as 2 weeks.

While IMVEXXY was studied over the course of 12 weeks, your healthcare provider may recommend that you continue with treatment to maintain vaginal health for relief from painful sex. IMVEXXY should be taken at the lowest effective dose and for the shortest duration consistent with your treatment goals and risks.

Why does IMVEXXY work and provide relief? Because it restores vaginal tissues and improves your vagina’s pH levels to address the underlying cause of your symptoms.

 

ULTRA-LOW DOSE ESTROGEN

WHAT A RELIEF.

If you’re thinking about starting estrogen, choose IMVEXXY, which is an ultra-low dose option in a softgel insert—in fact, it’s the lowest dose vaginal estrogen out there.*

IMVEXXY is the ONLY bio-identical estrogen softgel insert available. It replaces the estrogen you’ve lost during menopause with ultra-low dose estrogen that mimics the kind your body makes.*

*Bio-identical hormones are hormones that are structurally identical to the hormones your body produces naturally. It is not known if there is a difference in risks between synthetic hormones and bio-identical hormones.

 

MESS-FREE
ADMINISTRATION

No applicators.
No mess.
Yes, please.

Lotions, potions, lubes, and creams can be messy, inconvenient and often require applicators. And worst of all, these over-the-counter quick fixes don’t last beyond temporary relief.

Treat yourself, and the real root of the problem, with IMVEXXY.

IMVEXXY’s revolutionary design allows it to dissolve quickly, so it can treat the inside and outside of your vagina with mess-free administration and no downtime. And you can get relief without interrupting your day.

Ok, so how do
I get IMVEXXY?

You don’t have to wait until your annual check-up. Speak to a healthcare provider
now to see if IMVEXXY is right for you and learn how to get a prescription.

GET IMVEXXY

Important Risk Information

WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, PROBABLE DEMENTIA and BREAST CANCER

See full prescribing information for complete boxed warning.


Estrogen-Alone Therapy

  • There is an increased risk of endometrial cancer in a woman with a uterus who uses unopposed estrogens
  • The Women’s Health Initiative (WHI) estrogen-alone substudy reported increased risks of stroke and deep vein thrombosis (DVT)
  • The WHI Memory Study (WHIMS) estrogen-alone ancillary study of WHI reported an increased risk of probable dementia in postmenopausal women 65 years of age and older
  • Do not use estrogen-alone therapy for the prevention of cardiovascular disease or dementia

Estrogen Plus Progestin Therapy

  • The WHI estrogen plus progestin substudy reported increased risks of stroke, DVT, pulmonary embolism (PE) and myocardial infarction (MI)
  • The WHI estrogen plus progestin substudy reported increased risks of invasive breast cancer
  • The WHIMS estrogen plus progestin ancillary study of WHI reported an increased risk of probable dementia in postmenopausal women 65 years of age and older
  • Do not use estrogen plus progestogen therapy for the prevention of cardiovascular disease or dementia

The WHI estrogen-alone and estrogen plus progestin substudies evaluated only daily oral conjugated estrogens (CE) [0.625 mg] and medroxyprogesterone acetate (MPA) [2.5 mg]. Therefore, the relevance of the WHI findings regarding adverse cardiovascular events, dementia, and breast cancer to lower CE and MPA doses, other routes of administration, or other estrogen-alone or estrogen plus progestogen products is not known, and cannot be definitively excluded or determined.

MOST IMPORTANT INFORMATION YOU SHOULD KNOW ABOUT IMVEXXY(an estrogen hormone)

  • Using estrogen-alone may increase your chance of getting cancer of the uterus (womb).
  • Report any unusual vaginal bleeding right away while you are using IMVEXXY. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). Your healthcare provider should check any unusual vaginal bleeding to find out the cause.
  • Do not use estrogen-alone to prevent heart disease, heart attacks, strokes, or dementia (decline of brain function).
  • Using estrogen-alone may increase your chances of getting strokes or blood clots.
  • Using estrogen-alone may increase your chance of getting dementia, based on a study of women 65 years of age and older.
  • Do not use estrogens with progestogens to prevent heart disease, heart attacks, strokes or dementia.
  • Using estrogens with progestogens may increase your chance of getting dementia, based on a study of women 65 years of age and older.
  • Only one estrogen-alone product and dose have been shown to increase your chances of getting strokes, blood clots, and dementia. Only one estrogen with progestogen product and dose have been shown to increase your chances of getting heart attacks, strokes, breast cancer, blood clots, and dementia. Because other products and doses have not been studied in the same way, it is not known how the use of IMVEXXY will affect your chances of having these conditions.
  • Talk to your healthcare provider regularly about whether you still need treatment with IMVEXXY.

Do not use if you

  • have unusual vaginal bleeding.
  • have been diagnosed with a bleeding disorder.
  • currently have or have had certain cancers.
  • currently have or have had blood clots.
  • had a stroke or heart attack.
  • currently have or have had liver problems.
  • are allergic to IMVEXXY or any of its ingredients.

Warnings

Tell your healthcare provider about all of your medical conditions, including if you:

  • have any unusual vaginal bleeding.
  • have any other medical conditions that may become worse while you are using IMVEXXY.
  • have asthma (wheezing), epilepsy (seizures), diabetes, migraine, endometriosis, lupus, angioedema (swelling of face and tongue), problems with your heart, liver, thyroid, kidneys, or have high calcium levels in your blood.
  • are going to have surgery or will be on bed rest. You may need to stop using IMVEXXY.
  • are pregnant or think you may be pregnant. Imvexxy is not for pregnant women.
  • are breast feeding.

Tell your healthcare provider about all the medicines you take.

IMVEXXY may affect the way other medicines work, and other medicines may affect how IMVEXXY works.

When using IMVEXXY you may have

  • headache
  • breast tenderness or pain
  • nausea and vomiting

USE

IMVEXXY (estradiol vaginal inserts) is a prescription medicine that contains an estrogen hormone in a vaginal insert. It is used after menopause to treat moderate to severe painful intercourse, a symptom of changes in and around your vagina, due to menopause.



The risk information provided here is not complete. To learn more, talk about IMVEXXY with your healthcare provider or pharmacist. The FDA-approved product labeling can be found here.



You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch, or call 1-800-FDA-1088.

Please Wait